🔥 Monday 20 October 2025 Mon, 20 Oct 2025

Horizon Minerals reported steady gold production from Boorara and Phillips Find, unveiled promising high-grade drilling results at Burbanks, and acquired the Gordons Project near Black Swan, while progressing a key Pre-Feasibility Study for a gold processing plant conversion.

Kaiser Reef Limited has achieved a 33% increase in processing capacity at its Henty Gold Mine, with ongoing ramp-up activities and exploration efforts aiming to extend mine life and reduce costs.

Neuren Pharmaceuticals has secured FDA Fast Track designation for its drug NNZ-2591 targeting Phelan-McDermid syndrome, accelerating its path through clinical development. This milestone underscores the urgent need for treatments in rare neurodevelopmental disorders.

Horizon Gold advances its Gum Creek project with significant gold intercepts from water bore drilling and launches an AI-powered exploration platform, while maintaining its feasibility study timeline and securing $12 million in fresh capital.

TG Metals Limited reports multiple high-grade gold intercepts from its maiden drilling at the Tasman Pit within the Van Uden Gold Project, reinforcing plans to extend the pit and update resource models.

Bapcor reports a 2.7% revenue decline in 1Q26 and outlines a comprehensive operational review and cost-saving plan, setting cautious guidance for FY26.

Metal Powder Works Limited (MPW) has landed a $1 million contract with the US Navy for its innovative expeditionary DirectPowder™ unit, while expanding its alloy portfolio and customer base amid a $15 million capital raise.

Radiopharm Theranostics has completed a A$35 million institutional placement and launched a A$5 million Share Purchase Plan, both at $0.03 per share, to fund drug manufacturing and clinical trials through 2027.

Noronex Limited has secured a significant earn-in agreement with South32, enabling a A$5 million exploration program at the Cgae Cgae Copper Project in Botswana. This deal expands their strategic alliance and sets the stage for extensive drilling activity in the Kalahari Copper Belt.

Pivotal Metals has identified a substantial new electromagnetic conductor beneath its high-grade Alotta Cu-Ni-PGM-Au deposit in Quebec, revealing promising undrilled potential and reshaping exploration strategies across its Belleterre projects.

Resolution Minerals secures a $2 million placement from Tribeca Investment Partners, reinforcing its position in the U.S. critical minerals sector and advancing exploration at the strategically important Horse Heaven Project.

Wide Open Agriculture has developed a novel lupin protein milk formulation that overcomes longstanding technological hurdles, lodging a patent to protect its innovation and gearing up for global commercialisation.

Perpetual Limited reported a robust first quarter for FY26, with growth across its Asset Management, Corporate Trust, and Wealth Management divisions, driven by strong market returns and strategic initiatives.

Actinogen Medical has fast-tracked recruitment in its XanaMIA Alzheimer’s trial, closing pTau biomarker screening early and increasing participant numbers, aiming for final results by mid Q4 2026.

Kalamazoo Resources has significantly increased the Mt Olympus underground gold resource and identified a substantial exploration target, setting the stage for a potential mine life extension at the Ashburton Gold Project.

Beach Energy reported an 8% increase in production to 5.0 million barrels of oil equivalent in Q1 FY26, driven by strong performance in the Otway Basin and Cooper Basin flood recovery. Sales revenue rose 18% to $537 million, supported by two LNG cargoes from the Waitsia Gas Plant, which is now approaching its Ready For Start Up milestone.

Locksley Resources has produced the first 100% American made antimony ingot in decades, validating a fully domestic mine-to-metal supply chain and advancing U.S. critical minerals independence.

Rimfire Pacific Mining has announced a maiden Inferred Mineral Resource Estimate for its Currajong scandium prospect, boosting its total scandium inventory by 61% to 5,449 tonnes. The resource remains open for expansion, with further drilling planned at Murga and Rabbit Trap projects.

Race Oncology showcased compelling preclinical data at ESMO 2025 revealing that their drug RC220, combined with doxorubicin, not only shields the heart from toxicity but also boosts anticancer effects, supporting ongoing clinical trials.

Imricor Medical Systems has completed the world’s first Pulsed Field Ablation procedure under real-time MRI guidance, marking a breakthrough in cardiac ablation technology. This pre-clinical success validates their Vision-MR platform’s adaptability and sets the stage for safer, radiation-free heart treatments.

Orthocell has boosted its investment in Marine Biomedical to secure exclusive global distribution rights for PearlBone™, an innovative bone substitute nearing FDA approval, enhancing its regenerative medicine portfolio.

Koonenberry Gold has unveiled a major expansion of its Enmore Gold Project in NSW, identifying a 3km gold-in-soil anomaly along the Borah Fault and confirming high-grade gold mineralisation from historical drilling. The company is advancing a fully funded 10,000m drilling program to explore this district-scale opportunity.

BrainChip Holdings has initiated tape-out for its AKD1500 neuromorphic AI chip, targeting volume production by late Q3 2026 to meet rising demand for ultra-low-power edge AI solutions.

Prodigy Gold has reported a milestone with over one million ounces of gold in its resource inventory, alongside significant exploration progress and a successful $7.13 million capital raise to fund ongoing development.